Results 21 to 30 of about 1,282 (161)

Diagnosis and treatment of “chronic Lyme”: primum non nocere

BMC Infectious Diseases, 2023
Background Approximately 10% of patients experience prolonged symptoms after Lyme disease. PTLDS (post treatment Lyme disease syndrome) is a controversial topic. It has been described as a source of overdiagnosis and off-label treatment. This review aims
Prat Sébastien, Dalbin Jacques, Plotton Catherine, Gocko Xavier   +3 more
doaj   +1 more source

Update of the Swiss guidelines on post-treatment Lyme disease syndrome

Swiss Medical Weekly, 2016
Lyme borreliosis is caused by Borrelia burgdorferi sensu lato infection, which responds well to antibiotic therapy in the overwhelming majority of cases.
Johannes Nemeth, Enos Bernasconi, Ulrich Heininger, Mohamed Abbas, David Nadal, Carol Strahm, Stefan Erb, Stefan Zimmerli, Hansjakob Furrer, Julie Delaloye, Thierry Kuntzer, Ekkehard Altpeter, Mathias Sturzenegger, Rainer Weber, for the Swiss Society for Infectious Diseases and the Swiss Society for Neurology   +14 more
doaj   +1 more source

Exacerbation of chronic pain after dental extractions in a patient with post-treatment Lyme disease syndrome

Saudi Journal of Anaesthesia, 2018
A subset of patients who had Lyme disease experience postinfectious signs or symptoms called post-treatment Lyme disease syndrome (PTLDS). PTLDS is a chronic condition including pain in joints and muscles, neurological symptoms including demyelinating ...
Stephanie Lim, Sakura Kinjo
doaj   +1 more source

Posttransplant lymphoproliferative disorder in renal transplant recipients: Experience from a Tertiary Care Center

Saudi Journal of Kidney Diseases and Transplantation, 2021
Posttransplant lymphoproliferative disorders (PTLDs) are potentially fatal complications arising after solid organ or hematopoietic stem cell transplant.
Devika Gupta, Satish Mendonca, Rohit Tewari, Ankur Ahuja, Lavan Singh, Arun Joshi, Tathagata Chatterjee   +6 more
doaj   +1 more source

Posttransplant Lymphoproliferative Disorders

Advances in Hematology, 2012
Posttransplant lymphoproliferative disorders (PTLDs) are a group of diseases that range from benign polyclonal to malignant monoclonal lymphoid proliferations.
Hazem A. H. Ibrahim, Kikkeri N. Naresh
doaj   +1 more source

Health care costs, utilization and patterns of care following Lyme disease.

PLoS ONE, 2015
BackgroundLyme disease is the most frequently reported vector borne infection in the United States. The Centers for Disease Control have estimated that approximately 10% to 20% of individuals may experience Post-Treatment Lyme Disease Syndrome - a set of
Emily R Adrion, John Aucott, Klaus W Lemke, Jonathan P Weiner   +3 more
doaj   +1 more source

Risk Factors and Outcomes of Treatment Delays in Lyme Disease: A Population-Based Retrospective Cohort Study

Frontiers in Medicine, 2020
Background: Longer time between symptom onset and treatment of Lyme disease has been associated with poor outcomes. Reducing time-to-treatment requires knowledge of risks for treatment delays.
Annemarie G. Hirsch, Melissa N. Poulsen, Cara Nordberg, Katherine A. Moon, Alison W. Rebman, John N. Aucott, Christopher D. Heaney, Christopher D. Heaney, Christopher D. Heaney, Brian S. Schwartz, Brian S. Schwartz   +10 more
doaj   +1 more source

Efficacy and safety of antibiotic therapy for post-Lyme disease? A systematic review and network meta-analysis

BMC Infectious Diseases, 2023
Background At present, the pathogenesis of post-treatment Lyme disease (PTLDS) is not clear, so the treatment scheme of PTLDS, especially antibiotic treatment, is still controversial.
Xiaoqian Zhang, Yuwei Jiang, Yihan Chen, Jiaru Yang, Xiaoqi Zhang, Lu Xing, Aihua Liu, Fukai Bao   +7 more
doaj   +1 more source

Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome

Microorganisms, 2021
The hypothesized importance of coinfections in the pathogenesis of post-treatment Lyme disease syndrome (PTLDS) leads to the use of combined, ongoing antimicrobial treatment in many cases despite the absence of symptoms typical of the presence of ...
Kristyna Sloupenska, Jana Dolezilkova, Barbora Koubkova, Beata Hutyrova, Mojmir Racansky, Pavel Horak, Maryna Golovchenko, Milan Raska, Natalie Rudenko, Michal Krupka   +9 more
doaj   +1 more source

Florid follicular hyperplasia PTLD [PDF]

Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2018
Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of transplantation, which represent a heterogeneous group of lymphoproliferative diseases and show a spectrum of clinical, morphologic, and molecular genetic features ranging from reactive polyclonal lesions to frank lymphomas.
openaire   +2 more sources